ACA
VERA icon

Avoro Capital Advisors’s Vera Therapeutics VERA Stock Holding History

Avoro Capital Advisors’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$237M Hold
5,888,888
– – 2.33% 14
2025
Q4 		$298M Sell
5,888,888
-321,112
-5% -$11.4M 2.93% 13
2025
Q3 		$180M Sell
6,210,000
-90,000
-1% -$2.08M 2.33% 15
2025
Q2 		$148M Buy
6,300,000
+598,100
+10% +$13.4M 2.6% 15
2025
Q1 		$137M Buy
5,701,900
+91,900
+2% +$2.95M 2.14% 15
2024
Q4 		$237M Buy
5,610,000
+1,300,410
+30% +$57.6M 3.36% 9
2024
Q3 		$190M Hold
4,309,590
– – 2.78% 13
2024
Q2 		$156M Sell
4,309,590
-955,410
-18% -$37.9M 2.08% 16
2024
Q1 		$227M Buy
+5,265,000
New +$188M 2.65% 16

Other funds holding VERA

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $4.85B AUM 144% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.58B AUM 138.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2B AUM 117.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EP
Eversept Partners New York $1.52B AUM 121.13% 1-Year Est. Return